Firoze Khan, PhD

  • 1546 Citations
  • 24 h-Index
1980 …2022
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Firoze Khan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Rats Chemical Compounds
Trichloroethylene Chemical Compounds
Toxicity Chemical Compounds
Autoimmunity Medicine & Life Sciences
Spleen Medicine & Life Sciences
Oxidative stress Chemical Compounds
Lipids Chemical Compounds
Proteins Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2014 2022

Research Output 1980 2019

  • 1546 Citations
  • 24 h-Index
  • 83 Article
  • 1 Review article

Contribution of poly(ADP-ribose)polymerase-1 activation and apoptosis in trichloroethene-mediated autoimmunity

Wang, G., Ma, H., Wang, J. & Khan, M., Jan 1 2019, In : Toxicology and Applied Pharmacology. 362, p. 28-34 7 p.

Research output: Contribution to journalArticle

Trichloroethylene
Poly(ADP-ribose) Polymerases
Autoimmunity
Chemical activation
Apoptosis
5 Citations (Scopus)

Environmental agents, oxidative stress and autoimmunity

Khan, M. & Wang, G., Feb 1 2018, In : Current Opinion in Toxicology. 7, p. 22-27 6 p.

Research output: Contribution to journalReview article

Oxidative stress
Autoimmunity
Oxidative Stress
Autoimmune Diseases
Trichloroethylene

Altered miRNA expression in aniline-mediated cell cycle progression in rat spleen

Wang, G., Wang, J. & Khan, M., May 30 2017, (Accepted/In press) In : Toxicology Mechanisms and Methods. p. 1-7 7 p.

Research output: Contribution to journalArticle

MicroRNAs
Rats
Cell Cycle
Spleen
Cells
1 Citation (Scopus)

Autoimmune potential of perchloroethylene: Role of lipid-derived aldehydes

Wang, G., Wang, J., Ansari, G. & Khan, M., Oct 15 2017, In : Toxicology and Applied Pharmacology. 333, p. 76-83 8 p.

Research output: Contribution to journalArticle

Tetrachloroethylene
Aldehydes
Autoimmunity
Lipids
Malondialdehyde
43 Citations (Scopus)

Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials

on behalf of the EMBODY Investigator Group, Feb 1 2017, In : Arthritis and Rheumatology. 69, 2, p. 362-375 14 p.

Research output: Contribution to journalArticle

Systemic Lupus Erythematosus
Placebos
Safety
B-Lymphocytes
Therapeutics